Cargando…
Probing the drug delivery strategies in ischemic stroke therapy
Ischemic stroke, which is caused by a sudden clot in the blood vessels, may cause severe brain tissue damage and has become a leading cause of death globally. Currently, thrombolysis is the gold standard primary treatment of ischemic stroke in clinics. However, the short therapeutic window of opport...
Autores principales: | Wu, Qiong, Yan, Rong, Sun, Jingjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717707/ https://www.ncbi.nlm.nih.gov/pubmed/33241704 http://dx.doi.org/10.1080/10717544.2020.1850918 |
Ejemplares similares
-
Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy
por: Arul, Michael R., et al.
Publicado: (2023) -
Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke
por: Ma, Hongyin, et al.
Publicado: (2021) -
Advances of nano drug delivery system for the theranostics of ischemic stroke
por: Lv, Wei, et al.
Publicado: (2022) -
New strategies for ischemic stroke: internal photobiomodulation therapy
por: Iglesias-Rey, Ramón, et al.
Publicado: (2020) -
Tissue Acidosis Associated with Ischemic Stroke to Guide Neuroprotective Drug Delivery
por: M. Tóth, Orsolya, et al.
Publicado: (2020)